FenfluramineHypertension, PulmonaryAmphetamineAmphetaminesNorfenfluramineAppetite DepressantsHypertensionPulmonary ArteryHypertrophy, Right VentricularMetergolineMonocrotalineDexfenfluraminePersistent Fetal Circulation SyndromeSerotonin AgentsDiethylpropionAminorexp-ChloroamphetaminePulmonary CirculationDextroamphetamineCentral Nervous System StimulantsAnoxiaBlood PressureChlorphentermineAntihypertensive AgentsSerotoninN-Methyl-3,4-methylenedioxyamphetamineHypertension, PortalVascular ResistanceHemodynamicsHypertension, RenalSerotonin Uptake InhibitorsMethamphetaminePulmonary EmbolismRats, Sprague-DawleyPulmonary Wedge PressureVentricular Function, RightLungPhenmetrazine3,4-MethylenedioxyamphetamineIprindoleIloprostAmphetamine-Related DisordersVasodilator AgentsEmbalmingSulfonesVentricular Dysfunction, RightBone Morphogenetic Protein Receptors, Type IIBiogenic MonoaminesHypertension, RenovascularEpoprostenolMazindolEndarterectomyCyclobutanesTime FactorsPurinesCardiac CatheterizationPhenethylaminesHypertension, MalignantChronic DiseaseDopamineReceptor, Serotonin, 5-HT2BDose-Response Relationship, DrugSubstance Abuse DetectionNitric OxideSympathomimeticsClomipramineAdministration, InhalationMethylergonovineDisease Models, AnimalPhosphodiesterase 5 InhibitorsEndothelin-1Receptor, Serotonin, 5-HT1BPoisonsSerotonin AntagonistsFluorineNeurotransmitter Uptake InhibitorsBehavior, AnimalTyramineReceptors, SerotoninHeart Valve DiseasesHydroxyindoleacetic AcidMotor ActivityPiperazinesRisk FactorsMicrodialysisEchocardiography, DopplerCyclic Nucleotide Phosphodiesterases, Type 5Pulmonary Heart DiseaseArterial PressureHalofenateMuscle, Smooth, VascularPulmonary Veno-Occlusive DiseasePhosphodiesterase InhibitorsDrug InteractionsBody WeightEchocardiographyVasoconstrictionSerotonin Plasma Membrane Transport ProteinsStereotyped BehaviorReceptors, Endothelin